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Protein arginylation is a posttranslational modifica-
tion with an emerging global role in the regulation
of actin cytoskeleton. To test the role of arginylation
in the skeletal muscle, we generated a mouse model
with Ate1 deletion driven by the skeletal muscle-spe-
cific creatine kinase (Ckmm) promoter. Ckmm-Ate1
mice were viable and outwardly normal; however,
their skeletal muscle strength was significantly
reduced in comparison to controls. Mass spectrom-
etry of isolated skeletal myofibrils showed a limited
set of proteins, includingmyosin heavy chain, arginy-
lated on specific sites. Atomic force microscopy
measurements of contractile strength in individual
myofibrils and isolated myosin filaments from these
mice showed a significant reduction of contractile
forces, which, in the case of myosin filaments, could
be fully rescued by rearginylation with purified Ate1.
Our results demonstrate that arginylation regulates
force production in muscle and exerts a direct effect
on muscle strength through arginylation of myosin.
INTRODUCTION
Posttranslational addition of Arg to proteins (arginylation) is
mediated by arginyltransferase ATE1 (Balzi et al., 1990), an
enzyme that is conserved in all eukaryotic species and has
been recently proposed to carry global regulatory functions
(Kwon et al., 2002; Saha and Kashina, 2011; Wong et al.,
2007). In higher eukaryotes, ATE1 is essential for viability and
has been shown to target a variety of protein substrates and
affect the development and functioning of the cardiovascular
system, cell migration, and neural crest-dependent morphogen-
esis (Karakozova et al., 2006; Kurosaka et al., 2010, 2012; Kwon
et al., 2002; Saha and Kashina, 2011; Wong et al., 2007).
Recent studies from our lab identified over 100 proteins argi-
nylated in vivo, including a prominent subset of targets related
to the actin cytoskeleton (Kurosaka et al., 2012; Saha et al.,
2011; Wong et al., 2007). Arginylation of nonmuscle b-actin is
essential for normal cell migration and facilitates normal actin470 Cell Reports 8, 470–476, July 24, 2014 ª2014 The Authorsassembly (Karakozova et al., 2006; Saha et al., 2010). Arginyla-
tion of cardiac myofibril proteins facilitates the formation and
contractility of the heart muscle, and lack of arginylation leads
to age-related dilated cardiomyopathy in mice (Kurosaka et al.,
2012; Ribeiro et al., 2013). These results suggest that arginyla-
tion is involved in regulation in different types of actin-related
structures and may constitute a general mechanism regulating
the function of actin cytoskeleton in both muscle and nonmuscle
cells. However, the role of arginylation in different types of mus-
cle and the specific protein targets that drive arginylation-depen-
dent muscle contractility are unknown.
Here, we tested the role of ATE1 in the skeletal muscle by
generating a mouse model with Ate1 knockout (KO) driven by
skeletal muscle-specific creatine kinase (Ckmm) promoter.
Such Ckmm-Ate1 mice were viable and outwardly normal; how-
ever, their skeletal muscle strength was significantly reduced
compared to the control, without any visible changes in their
muscle mass or the ultrastructure of the skeletal myofibrils.
Atomic forcemicroscopy (AFM)measurements of the contractile
strength in the myofibrils isolated from the soleus muscle in
these mice showed a significant reduction of active contractile
forces. Mass spectrometry of the isolated skeletal myofibrils
showed a limited set of proteins arginylated in an intact form
on specific sites, including myosin heavy chain (MHC). AFM
measurements of isolated myosin filaments from Ate1 KO mice
showed similar changes as those in whole myofibrils, suggesting
that reduced contractile strength in Ate1 KO is to a large extent
dependent on myosin arginylation. Moreover, this force reduc-
tion of isolated myosin filaments was fully reversible by their
rearginylation using purified Ate1, suggesting that arginylation-
dependent regulation of myosin contractile strength constitutes
an on-and-off mechanism that controls the contractility of the
skeletal muscle. Our results demonstrate that arginylation regu-
lates force production in the muscle through modification of the
major components of the myofibrils and exerts a direct effect on
muscle strength by arginylation of the MHC.
RESULTS
Skeletal Muscle-Specific Ate1 KO Mice Exhibit Muscle
Weakness
We have previously found that Ate1 deletion in cardiacmyocytes
results in severe structural and contractile defects in the heart
Figure 1. Ckmm-Ate1 Mice Have Reduced
Skeletal Muscle Strength
(A) The duration of timeWT andCkmm-Ate1 (CKO)
mice were able to hang on a horizontal wire before
letting go.
(B) Grip-strength measurements for males and
females.
(C) Wire test falling score plotted against weight in
both groups.
(D) Changes in wire test falling score over time in
both groups. Error bars represent SEM. Mea-
surements in all tests included 10 WT and 28
Ckmm-Ate1 mice of both sexes, approximately
6 months of age. For wire test falling scores (C
and D), p value difference between the control and
the Ckmm-Ate1 groups equaled 1.22 3 1012
(determined by one-tailed paired t test).
See Figure S1 for the morphology of the skeletal
muscle, similar in WT and CKO mice.muscle (Kurosaka et al., 2012; Ribeiro et al., 2013). To test
whether similar effects can also be observed in the skeletal
muscle, we generated a conditional skeletal muscle-specific
mouse KO by crossing the previously described Ate1 floxed
mice (Kurosaka et al., 2010, 2012) with the commercially avail-
able mouse line expressing Cre recombinase under the skeletal
muscle-specific Ckmm promoter (Ckmm-Ate1 mice). In such
mice, Cre activation occurs in skeletal myocytes upon their dif-
ferentiation from myoblasts, resulting in complete deletion of
Ate1 in the skeletal muscle with no expected changes in any non-
muscle tissues.
Ckmm-Ate1 mice were viable, fertile, and outwardly normal
and showed no obvious defects in skeletal muscle appearance
or size. Ultrastructural studies of the soleus muscle from these
mice also showed no marked difference from their littermate
controls (Figure S1). On one occasion, a Ckmm-Ate1 mouse
developed complete atrophy of the hind leg muscles, resulting
in near-paralysis of the hind legs (Movie S1); however, this effect
was not seen in other mice.
A prominent subset of skeletal muscle disorders leads to
muscle weakness without pronounced changes in the appear-
ance or structure of the muscle. To compare the muscular
strength of Ckmm-Ate1 mice with their wild-type (WT) litter-
mates, we performed three different tests. First, mice were
tested for the duration of time they were able to spend hanging
on a horizontal wire before letting go, with their hind legs bound
together by a gentle restraint to prevent them from climbing onto
the wire. In this test, the majority of Ckmm-Ate1 mice were able
to hang on for less than 15 s, compared to the 15–30 s in the
control group (Figure 1A), suggesting that these mice were over-
all weaker than their WT littermates. Second, grip strength was
tested using a grip-strength meter (GSM), which measures the
ability of a mouse to hold onto a bar when pulled away by the
tail (Carbajal et al., 2009; Huang et al., 2014; Lafont et al.,
2009). In this test, both male and female KOmice had 30% lower
muscle strength measured as peak pull force of the forelimbs if
compared to that of the WT animals (86.1 ± 9.9 g [SE] versus
122.8 ± 9.8 g, p = 0.02; and 69.3 ± 3.6 g versus 99.6 ± 2.6 g,p = 0.0003 for males and females, respectively) (Figure 1B).
Finally, mice were accessed by wire test falling score, defined
as their ability to move hand over hand to the end of a horizontal
wire multiple times over a 180 s time period (with a starting score
of ten and each fall decreasing the score over time; Rafael et al.,
2000). In this test, mutant mice showed a greater dependence
of their falling score on weight, which is characteristic for
mouse models with muscular dystrophy (Rafael et al., 2000)
and indicates their inability to compensate for the increased
weight with their muscle strength (Figure 1C). In addition, mutant
mice also showed decreased ability to hold on over time,
frequently letting go of the wire and receiving progressively
decreasing wire test falling scores over the 180 s time period,
indicating their decreased muscle strength and durability with
continuous activity (Figure 1D). Overall, all these tests clearly
show that Ckmm-Ate1 mice have decreased muscle strength
without visible changes in any other characteristics of their
skeletal muscles.
Ate1 KO Leads to DecreasedMyofibril Contractile Force
To test whether the reduced muscle strength in Ckmm-Ate1
mice is directly related to the changes in intracellular contractile
forces, we tested the active forces developed by individual
myofibrils isolated from the soleus muscle of these mice, using
AFM (Huang et al., 2014; Karakozova et al., 2006; Labuda
et al., 2011). In these tests, the mutant mice exhibited significant
reduction in the active contractile force (Figures 2A and 2B),
which is developed by the myosin motor while interacting with
actin. In order to test if the decrease in contractile force was
associated with changes in the kinetics of the myosin cross
bridges interacting with actin, we measured the rates of force
development during initial activation (Kact) and after a shortening
protocol (Ktr), as well as the rate of relaxation following deactiva-
tion (Krel). All of these rates were lower in the Ckmm-Ate1 mice
(Figures 2A and 2C), suggesting changes in the actomyosin
kinetics cycle. SDS-PAGE analysis of the amount of MHCs in
control and Ckmm-Ate1muscles showed no significant changes
in either the total levels of MHC or the myosin:actin ratioCell Reports 8, 470–476, July 24, 2014 ª2014 The Authors 471
Figure 2. Atomic ForceMeasurements of IsolatedMyofibrils Show a
Decrease in Contractile Forces
(A) The active, isometric force in Ckmm-Ate1 myofibrils (KO, red) is significantly
weaker than in WT myofibrils (black). After full activation was obtained, the
myofibrils underwent a fast shortening protocol for measurements of force
redevelopment. The rates of force development during initial activation (Kact),
after the shorteningprotocol (Ktr), and the rateof relaxation followingdeactivation
(Krel)wereobtainedbyexponential fits to thedata.All parameterswere lowered in
Ckmm-Ate1 mice, suggesting changes in the actomyosin kinetics cycle.
(B) Mean values (±SEM) of the active forces produced by myofibrils of each
group.
(C) Mean values (±SEM) of the Kact (left), Ktr (middle), and Krel (right) produced
by myofibrils of each group.
(D) Gel electrophoresis results for detection of MHC andmyosin:actin ratio in a
typical muscle sample from WT and Ckmm-Ate1 (KO) muscles.
See also Figure S2.
Table 1. Proteins Arginylated in Skeletal Myofibrils
Accession
Number Name Arginylated Site
NP_033736.1 actin, a skeletal muscle E74
NP_038484.1 a-actinin-3 D456, D462, D465
NP_031736.1 creatine kinase M-type D326, D335
NP_001032850.1 F-actin-capping protein
subunit b isoform a
E22
NP_001034634.2 myosin heavy-chain IIa E1169
NP_034985.2 myosin heavy-chain IIb E887, E1005, E1012,
E1166, E1500
NP_666301.2 myosin-binding protein C,
fast-type isoform 2
E162
NP_001157138.1 troponin T, fast skeletal
muscle isoform 4
D63
NP_001157141.1 troponin T, fast skeletal
muscle isoform 5
D72
NP_038947.2 ubiquitin carboxyl
terminal hydrolase 21
D439(see Figure 2D for a representative gel). Thus, ATE1 appears to
directly regulate active myofibril contractile force.
Several Contractile Proteins Are Prominently
Arginylated in the Skeletal Myofibrils
In search for the potential mechanisms that link arginylation to
the contractile strength of the skeletal muscle, we analyzed iso-
lated skeletal myofibrils by mass spectrometry to identify which
proteins are arginylated in vivo in these preparations. This anal-
ysis revealed a total of eight proteins, each arginylated on one or
several specific sites (Table 1), including actin, MHC, myosin-
binding protein C, troponin T, a-actinin, actin-capping protein,
creatine kinase M, and Ub-C-terminal hydrolase 21. Arginylated
sites on these proteins are located on the surface of intact pro-
teins, within critical regions that play a role in the molecular inter-
actions and functioning of the contractile apparatus (Figure S3).
Most of these proteins constitute essential components of the
contractile apparatus in the muscle, and some of them directly
affect force generation during myofibril contraction (e.g., Acker-472 Cell Reports 8, 470–476, July 24, 2014 ª2014 The Authorsmann and Kontrogianni-Konstantopoulos, 2011; Bais and Ed-
wards, 1982; Bandman, 1992; Bo¨nnemann and Laing, 2004).
Myosin Arginylation Facilitates Myosin-Dependent
Force Production
To dissect the likely molecular mechanism behind the reduced
myofibril strength in the absence of arginylation and test the
contribution of arginylation of myosin—the primary player in
myofibril contractility—to the development of active contractile
force, we isolated individual myosin filaments from WT and
Ckmm-Ate1 mice and compared their performance while inter-
acting with actin filaments. First, we tested their ability to support
themovement of actin filaments in vitro using a sliding assay that
can measure the velocity of actin motility, reflecting the myosin
motor activity. We used commercial actin for these assays to
exclude the added effect of actin arginylation. In these assays,
both WT myosin and nonarginylated myosin were able to propel
actin filaments with similar velocity (WT, 1.09 ± 0.17; KO, 1.15 ±
0.15; t test, p = 0.29), suggesting that the myosin motor activity
was not affected by arginylation. This result is consistent with the
fact that all of the arginylated sites on myosin are located in the
rod region of the MHC, which mediates myosin self-association
and protein-protein interactions but has no direct bearing on the
activity of its motor head.
Next, we tested the force developed by the isolated myosin
filaments using microfabricated cantilevers of known stiffness
(Kalganov et al., 2010, 2013). In this assay, a myosin filament
attached to a cantilever is brought into contact with an actin fila-
ment that is attached to another cantilever coated with a-actinin.
When the filaments interact and myosin produces force, they
move the actin filament, causing deflection of the cantilever pro-
portional to the force, which reflects the strength and number of
cross bridges formed between myosin and actin (see Figure S4
for a diagram of the setup). We observed that the force produced
by nonarginylated myosin was significantly lower than control
(Figure 3), suggesting weakened assembly of the myosin cross
Figure 3. Arginylation of the Myosin Fila-
ments Facilitates Myosin-Dependent Con-
tractile Force
(A) The force produced during an interaction be-
tween actin and myosin was smaller for myosin
filaments isolated from Ckmm-Ate1 muscles (KO,
red) compared to WT (black).
(B) Mean values (±SEM) of the forces
produced by three groups of myosin filaments
isolated from WT, muscles, age-matched
Ckmm-Ate1 muscles (KO), and Ckmm-Ate1
muscles that have been rearginylated by purified
Ate1 (re-Arg). Note that forces produced by
myosin filaments from Ate1 KO are smaller than
WT, but the force is restored by rearginylation of
the filaments.
(C) SDS-PAGE of MHC (asterisk) from WT and Ckmm-Ate1 (KO) mice shows a gel shift between these two preparations (indicated by two lines on the lane
interface), suggesting that the majority of MHC in WT is arginylated.
See Figure S4 for the schematic representation of the measurement setup and Figure S5 for a typical preparation of myosin.bridges—the parameter that directly depends on the function-
ality and self-assembly properties of the myosin rod region.
To confirm that this effect was due to myosin rather than other
proteins present in the myosin filament preparations, we
analyzed these preparations by SDS-PAGE andmass spectrom-
etry (Figure S5) to determine if other proteins found on our list of
arginylatedmyofibril components shown in Table 1 were present
in sufficient quantities to potentially contribute to the weakened
force generation. This analysis revealed that myosin constituted
an overwhelming majority of the preparation. Remarkably, MHC
also showed a slight gel shift into the lower molecular weight in
the Ate1 KO, suggesting that the majority of this polypeptide
may be arginylated in WT (Figure 3C). Among the other proteins
present in the myosin filament preparation that have also been
found in the arginylated protein list shown in Table 1, the only
detectable band on SDS-PAGE belonged to actin, which overall
accounted for less than 5% of the preparation. Although the
presence of minor amounts of actin might have reduced the
overall efficiency of the assays, it should not have significantly
affected myosin-dependent force production on externally
added actin, which was present in the assays in overwhelming
excess. Thus, the reduced force developed by the isolated
myosin filaments from Ate1 KO muscle was due to the lack of
arginylation of the MHC rather than any additional polypeptides.
To confirm that this effect was dependent on myosin arginyla-
tion and not on any other properties of the myosin filament prep-
arations from Ate1 KO mice, we performed rescue assays, in
which nonarginylated myosin filaments were rearginylated
in vitro by purified Ate1. The rearginylated filaments were sub-
jected to the same force assay as the control and nonarginylated
filaments, using microfabricated cantilevers. Remarkably, rear-
ginylation by Ate1 completely rescued myosin-dependent force
to the control levels (Figure 3B), suggesting that reduced force
developed by myosin filaments from Ckmm-Ate1 mice directly
depends on arginylation.
DISCUSSION
Our study demonstrates a direct effect of arginylation on force
production in skeletal muscle, exerted through arginylation-dependent regulation of the myosin motor. We have previously
shown that arginylation affects cardiac myofibrillogenesis and
facilitates cardiac contractility, correlated with arginylation of
several myofibril proteins (Kurosaka et al., 2012; Rai et al.,
2008). The present work builds on this result and demonstrates
that arginylation likely plays a general role in regulating contrac-
tile strength of different types of muscles. Moreover, our finding
that arginylation can directly facilitate myosin-dependent skel-
etal myofibril force expands the scope of the known biological
effects of this emerging posttranslational modification and sug-
gests a global regulatory mechanism for myosin in muscle
contraction.
Myofibrils are the smallest structures of the skeletal muscles
that still maintain the 3D lattice intact, with all major proteins
present, providing a good experimental model for testing of the
effect of arginylation on the muscle strength at the subcellular
level. The use of this model points to several specific mecha-
nisms that are regulated by arginylation of the myofibril proteins.
The result that the specific contractile force (approximately 20%
change, normalized per cross-sectional area) is decreased in
Ckmm-Ate1 mice suggests that muscle weakness seen in these
mice in the absence of arginylation is caused by direct structural
changes in the myofibrillar contractile apparatus rather than via
effects provided by other intracellular or extracellular factors.
The observed reduction in force in the absence of arginylation
is similar at all sarcomere lengths investigated in this study, sug-
gesting that this effect is independent of the initial overlap
between myosin and actin filaments. Furthermore, because the
decrease in force in the Ckmm-Ate1 mice is accompanied by a
reduction in the rates of force development and redevelopment
Ktr, the arginylation-dependent force decrease is likely asso-
ciated with the kinetics of transition in myosin cross bridges,
shifting from weakly bound to strongly bound states. Although
arginylation of other proteins found in our study potentially con-
tributes to the overall reduction in the muscle strength seen in
Ckmm-Ate1 mice, the majority of these proteins are likely to
contribute either to the myofibril structural integrity and the pas-
sive force that maintain the myofibril rigidity and plasticity under
contraction (in the case of the structural myofibril proteins) or to
the regulation of the overall muscle contractility (creatine kinaseCell Reports 8, 470–476, July 24, 2014 ª2014 The Authors 473
Figure 4. Arginylation of the Myosin Rod Facilitates Myosin/Actin
Interaction in the Myofibril
Arginylation-induced conformational changes in the rod region of the MHC
ensure the increased number of cross bridges forming between actin and
myosin and facilitate cross-bridge kinetics. See also Figure S3.M) rather than exerting a direct effect onmyosin-dependent con-
tractile force. In support, the effect on the contractile force is
nearly as prominent in the isolated myosin filaments as that
seen in the myofibril preparations.
Myosin filaments isolated fromCkmm-Ate1mice produce less
force than control mice when normalized per filament overlap,
extending the result obtained with isolated myofibrils and sug-
gesting that the decrease in force observed in arginylation-defi-
cient myofibrils is producedmostly at the actin-myosin interface.
Because the myosin-driven sliding velocity of actin is not
changed by lack of arginylation, this decrease in force is likely
mediated not by a direct effect on the myosin motor activity
but via the reduction of the number of myosin cross bridges
attached to actin at a given time. Such reduction can be ex-
plained by the formation of filaments with fewer myosin bridges
or by a slower rate of myosin attachment to actin, as suggested
by our experiments with myofibrils. Both of these effects can
arise from the weakened myosin self-association in the absence
of arginylation within the rod of the heavy chain (Figure S3).
Based on our data, we believe that the downstream effect of
arginylation of the rod region on the myosin molecule results in
a conformational change that facilitates the association of the
myosin head with the actin filaments, resulting in normal cross-
bridge kinetics (Figure 4). In the absence of arginylation, this
conformational change cannot be easily achieved, and thus,
the number of myosin cross bridges associated with actin at a
given time is reduced. Dissecting the mechanisms of this regula-
tion in the context of the myosin motor complex constitutes an
exciting direction of further study.
Our data suggest that Ate1-mediated regulation of myofibrils
exhibits commonalities in different types of muscle, including
the previously characterized cardiac muscle (Kurosaka et al.,
2012) and the skeletal muscle described in the present study.
However, the heart muscle is apparently affected more severely
by the Ate1 KO, leading to marked structural abnormalities at all
developmental stages, in addition to the decreased contractile
force. The lack of similar structural abnormalities in the skeletal
muscle in Ckmm-Ate1 mice is likely explained by the fact that
this KO occurs much later in development, thus bypassing the
embryonic events that induce the early onset of skeletal myofi-474 Cell Reports 8, 470–476, July 24, 2014 ª2014 The Authorsbrillogenesis that generally occurs later than the formation of
the cardiac muscle. It is also possible that whereas arginylation
affects the contractile forces in both muscle types, it utilizes
different mechanisms for regulation of skeletal and cardiac
muscle. This possibility constitutes an exciting direction for
further studies.
EXPERIMENTAL PROCEDURES
Mice
All the animal procedures were performed in accordance with the standards
set by the University of Pennsylvania animal care and use committee. Mice
with Ate1 KO in the skeletal muscle were obtained by crossing an Ate1 floxed
mouse line, generated by targeted insertion of loxP sites upstream and down-
stream of the critical region of the Ate1 gene, with the Ckmm-Cre mouse line,
commercially available from the Jackson Laboratory. After crossing, Cre re-
combinase expression driven by skeletal muscle-specific creatine kinase
(Ckmm) promoter drives the deletion of Ate1 in skeletal muscle in the mice
that are homozygous for the floxed allele and express at least one copy of
the Cre transgene. Thesemice, termed Ckmm-Ate1, were compared with their
littermate controls containing no Cre and/or no floxed allele.
Grip Strength Measurements
The forelimb muscle strength was measured using a GSM (Ugo Basile)
according to the manufacturer’s instructions. Following a brief habituation
period, each mouse was positioned over a base plate and was allowed to
grasp a bar fitted to a force transducer connected to the peak amplifier. The
mouse was gently pulled back at a constant force until its grip was released.
The peak pull force achieved by the animal was monitored and recorded using
software supplied by the manufacturer. The test was repeated within a 30 s
interval, and the results were averaged for each mouse and subjected to the
statistical analysis. The significance of differences between the groups was
then examined using t test. When normality criteria were not fulfilled, nonpara-
metric analysis was performed with Mann-Whitney U test. All differences were
considered significant at p < 0.05 (Analyse-it software).
Myofibril Preparation
Small muscle bundles of the mouse soleus muscle were dissected from WT
and Ckmm-Ate1 mice, rinsed in rigor solution (50 mM Tris [pH 7.0], 100 mM
NaCl, 2 mM KCl, 2 mM MgCl2, and 10 mM EGTA), and tied to wood sticks.
The samples were stored in rigor/glycerol (50:50) solution for 15 hr at 20C
and then transferred to a fresh rigor/glycerol (50:50) solution containing a
cocktail of protease inhibitors (Roche Diagnostics) for at least 7 days.
Myofibril Force Measurements
On the day of the experiment, small pieces of the muscle were homogenized
with rigor solution following standard procedures used in our laboratory (Pun
et al., 2010; Rassier, 2008). The solution with myofibrils was transferred to
an experimental bath with a constant temperature of 10C filled with a low-cal-
cium relaxing solution (pCa2+ 9.0). Isolated myofibrils or doublets of myofibrils
with 10–15 sarcomeres in series were chosen for mechanical test. Under high
magnification with a 603 lens (Nikon plan-fluor, NA 0.70), the myofibrils were
glued to an atomic force cantilever (AFC) (model ATEC-CONTPt, Nanosen-
sors; mean stiffness, 0.2 nN 3 mm1) and a stiff glass microneedle (stiffness
>2,000 nN 3 mm1). The myofibrils were lifted from the glass coverslip by
approximately 150 mm. With this system, a laser is shined upon and reflects
from the AFC, which acts as a force transducer. The AFC deflects when an
attached myofibril is shortened due to activation. The cantilever deflection is
detected and recorded using a newly developed optical system that allows
for high time-resolution measurements, containing an optical periscope and
a photoquadrant detector. Because the stiffness of the AFCs (K) was known
and we measured the amount of cantilever displacement (Dd), the force (F)
could be calculated as F = K 3 Dd. Before each experiment, the stiffness of
AFC was confirmed using a bending method against a glass needle of known
stiffness. The length and diameter of the myofibrils were measured, and the
cross-sectional was calculated assuming a circular geometry.
A computer-controlled, multichannel fluidic system connected to a double-
barreled pipette (Pun et al., 2010; Rassier, 2008) was used for activation/deac-
tivation of the myofibrils (relaxing pCa2+ 9.0, activating pCa2+ 4.5). Length
changes during the experiments were induced with a rigid microneedle con-
nected to a piezo motor. Under high magnification, the contrast between the
dark bands of myosin (A bands) and the light bands of actin (I bands) provided
a dark-light intensity pattern, representing the striation pattern produced by
the sarcomeres, which allowed measurements of sarcomere length during
the experiments.
Once themyofibrils were attached to the AFCs andmicroneedles, they were
adjusted to average sarcomere lengths between 2.2 and 3.6 mm (random
order) to test the active force production at different lengths. The solution
surrounding the myofibrils was changed from pCa2+ 9.0 to pCa2+ 4.5, which
caused activation and force development. Once the myofibrils were fully
activated and maximal force was obtained, they underwent a shortening-
stretching protocol (amplitude 30% of sarcomere length; speed 10 mm/s; in-
terval between length changes 5 ms), during which the force declined and
rapidly redeveloped to reach a new steady state. The maximal force produced
by the myofibrils was calculated after force development stabilization and af-
ter force redevelopment following the shortening-stretch protocol. Forces
were averaged for a period of 2 s to avoid potential effects of artifacts inter-
fering with the measured values. The passive forces produced by myofibrils
during the stretching protocol were calculated when the force was stabilized
at every new sarcomere length. All forces were normalized by the myofibril
cross-sectional area assuming circular geometry. For each contraction, Kact
and Ktr were analyzed with a two-exponential equation (a 3 (1exp(k 3 t)
exp(l3 t))+b), and the Krel was analyzed with a single-exponential equation
(a3 exp(k3 (tc))+b). For both equations, ‘‘F’’ is force, ‘‘t’’ is time, ‘‘K1’’ and
‘‘K2’’ are rate constants for force development, ‘‘a’’ is the amplitude of the ex-
ponential(s), and ‘‘b’’ is the initial force value.
Biochemical Processing and MHC Electrophoresis
A total of 25 mg of frozen muscle fragments was placed in 0.5 ml solution con-
taining 1MTris/HCl buffer (pH 7.4), 1MNaCl, 0.1MEDTA, 10% (w/v) SDS, and
protease inhibitors (Roche Diagnostics). The extracts were heated at 100C for
5 min in sample buffer containing 0.5 M Tris/HCl buffer (pH 6.8), glycerol, 10%
(w/v) SDS, 0.5% (w/v) bromophenol blue, and 5% (v/v) 2-mercaptoethanol.
Portions (40 mg) of each sample were analyzed by electrophoresis (SDS-
PAGE 6%) using a 4% stacking gel for 2 hr at 120 V. The gels were stained
with Coomassie blue. To determine the relative MHC contents, the stained
gels were scanned using conventional scanner (CanoScan LiDE110; Canon).
Isolation of Native Myosin Filaments
Myosin filaments were isolated from WT and Ckmm-Ate1 mice according to
standard procedures (Walker et al., 1985) with minor modifications. Briefly,
muscle samples stored in rigor solution mixed with glycerol were defrosted
overnight at 0C in solution containing 140 mM NaCl, 2 mM MgCl2, 10 mM
EGTA, 10 mM PIPES, and 2 mM DTT (pH 7.4). Muscles were diced and trans-
ferred to a cold solution containing 75 mM KCl, 2 mM MgCl2, 10 mM EGTA,
10mMPIPES, 10mMATP, and 2mMDTT (pH 7.0). The samples were homog-
enized (SNMX 1092; Omni) 23 for 30 s, with 1min intervals. A total of 25 mM of
KCl was added to the homogenate, and it was maintained for 2 hr at 0C. The
homogenate was centrifuged at 4,500 3 g for 30 min (5804R; Eppendorf) and
the supernatant diluted 43 in order to reduce the ionic strength and promote
filament aggregation. The solution containing the filaments was kept overnight
at 0C. The next day, the solution was centrifuged at 4,5003 g for 90 min, and
the pellet was resuspended in 140 mM KCl, 2 mMMgCl2, 2 mM EGTA, 10 mM
PIPES, and 2 mM DTT (pH 7.0).
Cardiac acetone actin powder (Sigma-Aldrich) was polymerized to obtain
actin filaments. The filaments were labeled using Alexa 488-phalloidin fluores-
cence dye (absorption/emission peaks at 488–520 nm). a-actinin (A9776;
Sigma-Aldrich) was dialyzed against AB buffer 25 mM Imidazole-HCl,
25 mM KCl, 4 mM MgCl2, 1 mM EGTA, and 1 mM DTT.
Force Measurements in Myosin Filaments
The experimental chamber was mounted on an inverted microscope (Nikon;
TE2000-U) equipped for bright-, dark-field, and/or fluorescence imaging.Dark-field illumination was used to image myosin filaments (Labuda et al.,
2011). Fluorescencemicroscopy was used to image actin filaments with a filter
set for Alexa 488 (Exciter ET470/403, Dichroic T495LP, Emitter ET525/50 m,
Chroma). Imageswere capturedwith a Rolera-MGi Plus video camera (QImag-
ing) and recorded using StreamPix4 software (NorPix; pixel size, 150 nm; rate,
30 fps).
Microfabricated cantilevers were used for measurements of force during
myosin-actin interactions. The cantilevers were made out of thick silicon
nitride wafer, which was followed by a photolithography process as previously
used in our laboratory (Labuda et al., 2011). The cantilever tips were coated
with a 50 nm gold layer in order to increase their optical contrast. The final stiff-
ness of the cantilevers was obtained using a resonance frequency detection
method as previously described by Labuda et al. (2011). The cantilevers
were glued to the bottom of themetal holders, whichwere connected tomicro-
manipulators that allow 3D manipulation inside of the experimental chamber
(Figure 1A).
The cantilevers attached to the metal holders were placed in the experi-
mental chamber within a distance of 10–15 mm. A total of 10 ml of myosin
filament solution was added near the right cantilever, and 10 ml of a-actinin
solution was added near the left cantilever, followed by a 10 min incubation
period. A flow of standard AB/BSA/GOC/ATP solution (AB) (0.5 mg/ml BSA,
0.018 mg/ml catalase, 0.1 mg/ml glucose oxidase, 3 mg/ml glucose, 20 mM
DTT, and 50 mM ATP) was injected into the chamber with a syringe pump
(Pump 33; Harvard Apparatus) at a speed of 0.5 ml/min to wash the excess
a-actinin and myosin filaments. After 2 min, the left and the right cantilevers
were moved into close proximity to each other to appear in the microscope’s
field of view (1003 magnification). Fluorescently labeled actin filaments
(concentration, 2–4 nM) were injected into the chamber, and the flow facili-
tated their spontaneous attachment to the a-actinin-coated left cantilever;
a-actinin is one of the major components of the Z disk in muscle sarcomeres
and has high affinity for actin filaments. The flow was maintained constant to
align the actin filaments approximately 90 perpendicular to the cantilevers.
Myosin filaments were injected into the chamber and adhered to the right
cantilever spontaneously; due to their stiffness, they did not bend with the
continuous flow.
One actin filament and onemyosin filament attached at or close to the canti-
lever tips (<50 mm from the tip) were chosen and brought closer to each other.
Once the filaments interacted, they initiated force production and con-
sequently displacement of the cantilevers, which was tracked with ImageJ
software (NIH). The forces were calculated from the displacements of the can-
tilevers as explained previously (Kalganov et al., 2010, 2013). Briefly, the force
(F) was calculated as F = K 3 Ad (cantilever displacement). The alignment of
the filaments at times was not at 90 angle to the cantilever; in these cases,
the force component on the vertical axis during cantilever displacement was
enhanced by an angular component represented by the vertical axis. The full
force generated by the filaments during interaction is therefore F = Fx + Fy,
where ‘‘Fx’’ is the vector component of force along the horizontal axis, and
‘‘Fy’’ is the vector component of force along the vertical axis. The images of
the cantilever displacements were analyzed using an automatic algorithm
(ABSnake for ImageJ; NIH).
Electron Microscopy Analysis
Soleus muscles excised from the legs of adult mice were washed in PBS and
fixed in situ during excision with 2.5% glutaraldehyde and 2% paraformalde-
hyde in buffer C (0.1 M sodium cacodylate [pH 7.4]) followed by fixation over-
night at 4C, two 10 min washes in buffer C, and postfixation in 2% osmium
tetroxide in buffer C. Muscles were washed twice for 10 min each in buffer
C, once for 10 min in distilled water, incubated 1 hr at room temperature in
a 2% aqueous solution of uranyl acetate, and then washed twice for 10 min
each in distilled water, dehydrated by incubation for 10 min each in 50%,
70%, 80%, 90%, and 100% ethanol followed by two 5 min incubations in
propylene oxide (PO), overnight incubation in 1:1 PO:Epon (Poly/Bed 812,
Polysciences), and 1 day in 100% Epon. Epon-embedded samples were
kept for 2 days at 60C for Epon polymerization, sectioned, stained with 1%
uranyl acetate in 50% methanol and with a 2% (w/v) solution of bismuth
subnitrite at 1:50 dilution, and overlaid onto Formvar-coated grids for electron
microscopy.Cell Reports 8, 470–476, July 24, 2014 ª2014 The Authors 475
Mass Spectrometry
Identification of arginylated proteins by mass spectrometry was performed on
isolated myofibrils as described in Wong et al. (2007) and Xu et al. (2009).
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